• 検索結果がありません。

Immune thrombocytopenia during interferon-alfa therapy for renal cell carcinoma - 見る/開く

N/A
N/A
Protected

Academic year: 2022

シェア "Immune thrombocytopenia during interferon-alfa therapy for renal cell carcinoma - 見る/開く"

Copied!
5
0
0

読み込み中.... (全文を見る)

全文

(1)

RIGHT:

URL:

CITATION:

AUTHOR(S):

ISSUE DATE:

TITLE:

Immune thrombocytopenia during interferon-alfa therapy for renal cell carcinoma

Akamatsu, Shusuke; Asazuma, Akira; Kanamaru, Sojun; Takenawa, Jun; Soeda, Asaki

Akamatsu, Shusuke ...[et al]. Immune thrombocytopenia during interferon-alfa therapy for renal cell carcinoma. 泌尿器科紀要 2006, 52(10): 789-792

2006-10

http://hdl.handle.net/2433/71253

(2)
(3)
(4)
(5)

参照

関連したドキュメント

Early Years of Serikat Buruh Kereta Api (Railway Workers Union, SBKA): Formation

Evaluation of hematuria and proteinuria positivity in relation to ageing in 6,651 apparently healthy men

NELL1 (a) and NELL2 (b) mRNA expression levels in renal cell carcinoma cell lines OS-RC-2, VMRC-RCW, and TUHR14TKB and control HEK293T cells were analyzed using quantitative

 In conclusion, IFN-α alternation therapy is one treatment option for mRCC patients in whom first- line IFN-α treatment failed if the patient has only lung or

Groundwater Modeling Coupled with SVAT Model and its Application to the Yasu River

Insulin and glucagon levels in living related liver transplantation : Their interaction with the recovery of graft liver function(.

LABORATORIES OF VISITING PROFESSORS: Solid State Chemistry / Fundamental Material Properties / Synthetic Organic Chemistry / International Research Center for Elements Science

Late relapse of testicular cancer 21 years after first complete remission: a